Trial Profile
Prospective, Randomized, Double-blind Controlled Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing Agent at Skin Donor Sites
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary)
- Indications Pain
- Focus Therapeutic Use
- 13 Dec 2018 Status changed from recruiting to withdrawn prior to enrolment.
- 13 Dec 2018 Planned End Date changed from 1 Jun 2020 to 14 Nov 2018.
- 13 Dec 2018 Planned primary completion date changed from 1 Jun 2020 to 14 Nov 2018.